A multicenter, Phase 3, randomized, open label, active-controlled, parallel-group study investigating safety, tolerability and efficacy of Transcon hGH administered once-a-week versus standard daily rhGH

Project: Research

Status	Finished
Effective start/end date	03/31/17 → 08/31/21

Project Details